<DOC>
	<DOCNO>NCT00204243</DOCNO>
	<brief_summary>The purpose clinical trial study efficacy safety naltrexone implant relapse prevention opiate addict inmate release prison . The experimental group compare control group commence methadone maintenance treatment release . The hypothesis quality life criminal behaviour improve significantly group compare month incarceration . The experimental group go significant less day opioid use compare MMT group . We hypothesize furthermore implant prevent death related opiate overdose 6 month commence treatment .</brief_summary>
	<brief_title>Naltrexone Implants vs. MMT Among Inmates Norwegian Correctional Services</brief_title>
	<detailed_description>The probability quick relapse criminal activity substance abuse prison release high among incarcerated opiate addict . We attempt prevent relapse opiate abuse two different mean : Methadone Maintenance Treatment ( MMT ) versus Naltrexone implant , randomly allocate two group seal envelope . All participant may choose group continue 6 ( 12 ) month , implant supposedly stop release naltrexone . The total treatment period 18 month , continuation MMT optional study termination .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>opiate addiction living great Oslo area psychosis / major depression , currently treat pregnancy liver enzyme : ASAT ALAT &gt; threefold upper boundary</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>naltrexone implant</keyword>
	<keyword>methadone</keyword>
	<keyword>inmate</keyword>
	<keyword>randomize control trial</keyword>
</DOC>